nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCC2—type 2 diabetes mellitus	0.191	0.694	CbGaD
Indinavir—CYP3A4—type 2 diabetes mellitus	0.0846	0.306	CbGaD
Indinavir—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0311	0.0608	CbGbCtD
Indinavir—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0281	0.055	CbGbCtD
Indinavir—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0266	0.0519	CbGbCtD
Indinavir—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.026	0.0507	CbGbCtD
Indinavir—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0229	0.0448	CbGbCtD
Indinavir—ABCC1—Glyburide—type 2 diabetes mellitus	0.0171	0.0334	CbGbCtD
Indinavir—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0153	0.0298	CbGbCtD
Indinavir—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0132	0.0257	CbGbCtD
Indinavir—ABCC2—Glyburide—type 2 diabetes mellitus	0.0127	0.0247	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0125	0.0244	CbGbCtD
Indinavir—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0125	0.0244	CbGbCtD
Indinavir—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0125	0.0244	CbGbCtD
Indinavir—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0118	0.023	CbGbCtD
Indinavir—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0115	0.0224	CbGbCtD
Indinavir—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0112	0.0218	CbGbCtD
Indinavir—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0105	0.0205	CbGbCtD
Indinavir—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00999	0.0195	CbGbCtD
Indinavir—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00999	0.0195	CbGbCtD
Indinavir—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00977	0.0191	CbGbCtD
Indinavir—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00939	0.0183	CbGbCtD
Indinavir—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00922	0.018	CbGbCtD
Indinavir—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00891	0.0174	CbGbCtD
Indinavir—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00831	0.0162	CbGbCtD
Indinavir—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00831	0.0162	CbGbCtD
Indinavir—SLC22A1—Metformin—type 2 diabetes mellitus	0.00816	0.0159	CbGbCtD
Indinavir—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00806	0.0157	CbGbCtD
Indinavir—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00767	0.015	CbGbCtD
Indinavir—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0076	0.0148	CbGbCtD
Indinavir—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0075	0.0146	CbGbCtD
Indinavir—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0074	0.0145	CbGbCtD
Indinavir—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00701	0.0137	CbGbCtD
Indinavir—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00677	0.0132	CbGbCtD
Indinavir—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00668	0.013	CbGbCtD
Indinavir—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0063	0.0123	CbGbCtD
Indinavir—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00611	0.0119	CbGbCtD
Indinavir—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00604	0.0118	CbGbCtD
Indinavir—CYP3A5—Losartan—type 2 diabetes mellitus	0.0058	0.0113	CbGbCtD
Indinavir—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00576	0.0112	CbGbCtD
Indinavir—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00554	0.0108	CbGbCtD
Indinavir—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00552	0.0108	CbGbCtD
Indinavir—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00534	0.0104	CbGbCtD
Indinavir—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00512	0.00999	CbGbCtD
Indinavir—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00483	0.00943	CbGbCtD
Indinavir—CYP2C19—Losartan—type 2 diabetes mellitus	0.00468	0.00914	CbGbCtD
Indinavir—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00425	0.00831	CbGbCtD
Indinavir—ABCB1—Glyburide—type 2 diabetes mellitus	0.00413	0.00806	CbGbCtD
Indinavir—CYP2C9—Losartan—type 2 diabetes mellitus	0.00389	0.0076	CbGbCtD
Indinavir—ABCB1—Losartan—type 2 diabetes mellitus	0.00377	0.00737	CbGbCtD
Indinavir—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00366	0.00715	CbGbCtD
Indinavir—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00351	0.00685	CbGbCtD
Indinavir—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00351	0.00685	CbGbCtD
Indinavir—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00332	0.00648	CbGbCtD
Indinavir—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00247	0.00483	CbGbCtD
Indinavir—CYP3A4—Losartan—type 2 diabetes mellitus	0.00226	0.00442	CbGbCtD
Indinavir—Saquinavir—CYP11A1—type 2 diabetes mellitus	0.000683	0.26	CrCbGaD
Indinavir—Lopinavir—CYP1A2—type 2 diabetes mellitus	0.000393	0.15	CrCbGaD
Indinavir—Saquinavir—ABCC2—type 2 diabetes mellitus	0.000375	0.143	CrCbGaD
Indinavir—Nelfinavir—CYP1A2—type 2 diabetes mellitus	0.000365	0.139	CrCbGaD
Indinavir—Lopinavir—CYP3A4—type 2 diabetes mellitus	0.00026	0.099	CrCbGaD
Indinavir—Nelfinavir—CYP3A4—type 2 diabetes mellitus	0.000242	0.092	CrCbGaD
Indinavir—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000168	0.0625	CbGeAlD
Indinavir—Saquinavir—CYP3A4—type 2 diabetes mellitus	0.000166	0.0631	CrCbGaD
Indinavir—Saquinavir—ALB—type 2 diabetes mellitus	0.000145	0.055	CrCbGaD
Indinavir—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000144	0.0535	CbGeAlD
Indinavir—SLCO1B1—kidney—type 2 diabetes mellitus	0.000119	0.0443	CbGeAlD
Indinavir—CYP3A7—liver—type 2 diabetes mellitus	0.00011	0.0408	CbGeAlD
Indinavir—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000103	0.0382	CbGeAlD
Indinavir—SLC22A1—kidney—type 2 diabetes mellitus	0.0001	0.0374	CbGeAlD
Indinavir—SLCO1A2—kidney—type 2 diabetes mellitus	9.67e-05	0.036	CbGeAlD
Indinavir—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	9.31e-05	0.0347	CbGeAlD
Indinavir—SLC22A1—adipose tissue—type 2 diabetes mellitus	9.05e-05	0.0337	CbGeAlD
Indinavir—ABCC2—kidney—type 2 diabetes mellitus	9.01e-05	0.0336	CbGeAlD
Indinavir—ABCC2—cortex of kidney—type 2 diabetes mellitus	8.78e-05	0.0327	CbGeAlD
Indinavir—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	8.62e-05	0.0321	CbGeAlD
Indinavir—ABCC1—cortex of kidney—type 2 diabetes mellitus	7.73e-05	0.0288	CbGeAlD
Indinavir—SLCO1B1—liver—type 2 diabetes mellitus	7.51e-05	0.028	CbGeAlD
Indinavir—ABCC1—adipose tissue—type 2 diabetes mellitus	7.15e-05	0.0267	CbGeAlD
Indinavir—CYP3A5—nephron tubule—type 2 diabetes mellitus	6.94e-05	0.0259	CbGeAlD
Indinavir—Oedema—Metformin—type 2 diabetes mellitus	6.77e-05	0.000451	CcSEcCtD
Indinavir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.75e-05	0.000449	CcSEcCtD
Indinavir—Flushing—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000448	CcSEcCtD
Indinavir—Angioedema—Losartan—type 2 diabetes mellitus	6.74e-05	0.000448	CcSEcCtD
Indinavir—Insomnia—Valsartan—type 2 diabetes mellitus	6.73e-05	0.000448	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.7e-05	0.000446	CcSEcCtD
Indinavir—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.68e-05	0.000444	CcSEcCtD
Indinavir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.67e-05	0.000444	CcSEcCtD
Indinavir—Myalgia—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.000444	CcSEcCtD
Indinavir—Chest pain—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.000444	CcSEcCtD
Indinavir—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.000444	CcSEcCtD
Indinavir—Shock—Metformin—type 2 diabetes mellitus	6.66e-05	0.000444	CcSEcCtD
Indinavir—Insomnia—Orlistat—type 2 diabetes mellitus	6.65e-05	0.000442	CcSEcCtD
Indinavir—Malaise—Losartan—type 2 diabetes mellitus	6.65e-05	0.000442	CcSEcCtD
Indinavir—Anxiety—Irbesartan—type 2 diabetes mellitus	6.65e-05	0.000442	CcSEcCtD
Indinavir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.64e-05	0.000442	CcSEcCtD
Indinavir—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.64e-05	0.000442	CcSEcCtD
Indinavir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.63e-05	0.000441	CcSEcCtD
Indinavir—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.63e-05	0.000441	CcSEcCtD
Indinavir—Vertigo—Losartan—type 2 diabetes mellitus	6.62e-05	0.000441	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.000441	CcSEcCtD
Indinavir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.62e-05	0.000441	CcSEcCtD
Indinavir—Somnolence—Valsartan—type 2 diabetes mellitus	6.61e-05	0.00044	CcSEcCtD
Indinavir—Syncope—Losartan—type 2 diabetes mellitus	6.61e-05	0.00044	CcSEcCtD
Indinavir—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.6e-05	0.000439	CcSEcCtD
Indinavir—Discomfort—Irbesartan—type 2 diabetes mellitus	6.59e-05	0.000438	CcSEcCtD
Indinavir—Skin disorder—Metformin—type 2 diabetes mellitus	6.58e-05	0.000438	CcSEcCtD
Indinavir—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000436	CcSEcCtD
Indinavir—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.55e-05	0.000436	CcSEcCtD
Indinavir—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.55e-05	0.000436	CcSEcCtD
Indinavir—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.52e-05	0.000434	CcSEcCtD
Indinavir—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000434	CcSEcCtD
Indinavir—Palpitations—Losartan—type 2 diabetes mellitus	6.51e-05	0.000433	CcSEcCtD
Indinavir—Nausea—Glimepiride—type 2 diabetes mellitus	6.49e-05	0.000432	CcSEcCtD
Indinavir—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.48e-05	0.000431	CcSEcCtD
Indinavir—Nausea—Sitagliptin—type 2 diabetes mellitus	6.47e-05	0.000431	CcSEcCtD
Indinavir—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.47e-05	0.000431	CcSEcCtD
Indinavir—Asthenia—Glyburide—type 2 diabetes mellitus	6.47e-05	0.000431	CcSEcCtD
Indinavir—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.47e-05	0.00043	CcSEcCtD
Indinavir—Anorexia—Metformin—type 2 diabetes mellitus	6.46e-05	0.00043	CcSEcCtD
Indinavir—Cough—Losartan—type 2 diabetes mellitus	6.43e-05	0.000428	CcSEcCtD
Indinavir—Urticaria—Gliclazide—type 2 diabetes mellitus	6.43e-05	0.000428	CcSEcCtD
Indinavir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000427	CcSEcCtD
Indinavir—Alopecia—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000427	CcSEcCtD
Indinavir—Fatigue—Valsartan—type 2 diabetes mellitus	6.41e-05	0.000427	CcSEcCtD
Indinavir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.4e-05	0.000426	CcSEcCtD
Indinavir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.4e-05	0.000426	CcSEcCtD
Indinavir—Oedema—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000425	CcSEcCtD
Indinavir—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000425	CcSEcCtD
Indinavir—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.39e-05	0.000425	CcSEcCtD
Indinavir—Pruritus—Glyburide—type 2 diabetes mellitus	6.38e-05	0.000425	CcSEcCtD
Indinavir—Constipation—Valsartan—type 2 diabetes mellitus	6.36e-05	0.000423	CcSEcCtD
Indinavir—SLC22A1—liver—type 2 diabetes mellitus	6.35e-05	0.0237	CbGeAlD
Indinavir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.35e-05	0.000422	CcSEcCtD
Indinavir—Fatigue—Orlistat—type 2 diabetes mellitus	6.34e-05	0.000422	CcSEcCtD
Indinavir—Malnutrition—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000421	CcSEcCtD
Indinavir—Shock—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000419	CcSEcCtD
Indinavir—Pain—Orlistat—type 2 diabetes mellitus	6.29e-05	0.000418	CcSEcCtD
Indinavir—Arthralgia—Losartan—type 2 diabetes mellitus	6.28e-05	0.000418	CcSEcCtD
Indinavir—Myalgia—Losartan—type 2 diabetes mellitus	6.28e-05	0.000418	CcSEcCtD
Indinavir—Chest pain—Losartan—type 2 diabetes mellitus	6.28e-05	0.000418	CcSEcCtD
Indinavir—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.27e-05	0.000417	CcSEcCtD
Indinavir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000417	CcSEcCtD
Indinavir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.26e-05	0.000417	CcSEcCtD
Indinavir—Anxiety—Losartan—type 2 diabetes mellitus	6.25e-05	0.000416	CcSEcCtD
Indinavir—Rash—Bromocriptine—type 2 diabetes mellitus	6.22e-05	0.000414	CcSEcCtD
Indinavir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.21e-05	0.000413	CcSEcCtD
Indinavir—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000413	CcSEcCtD
Indinavir—Tension—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000413	CcSEcCtD
Indinavir—Discomfort—Losartan—type 2 diabetes mellitus	6.2e-05	0.000413	CcSEcCtD
Indinavir—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000412	CcSEcCtD
Indinavir—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000411	CcSEcCtD
Indinavir—Headache—Bromocriptine—type 2 diabetes mellitus	6.18e-05	0.000411	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.17e-05	0.000411	CcSEcCtD
Indinavir—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.17e-05	0.000411	CcSEcCtD
Indinavir—Nervousness—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000409	CcSEcCtD
Indinavir—Dry mouth—Losartan—type 2 diabetes mellitus	6.14e-05	0.000408	CcSEcCtD
Indinavir—CYP2C9—cardiovascular system—type 2 diabetes mellitus	6.14e-05	0.0229	CbGeAlD
Indinavir—SLCO1A2—liver—type 2 diabetes mellitus	6.11e-05	0.0228	CbGeAlD
Indinavir—CYP3A5—kidney—type 2 diabetes mellitus	6.1e-05	0.0227	CbGeAlD
Indinavir—Anorexia—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000406	CcSEcCtD
Indinavir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.08e-05	0.000405	CcSEcCtD
Indinavir—Paraesthesia—Metformin—type 2 diabetes mellitus	6.08e-05	0.000405	CcSEcCtD
Indinavir—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000404	CcSEcCtD
Indinavir—CYP3A5—pancreas—type 2 diabetes mellitus	6.06e-05	0.0226	CbGeAlD
Indinavir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.06e-05	0.000403	CcSEcCtD
Indinavir—Dyspnoea—Metformin—type 2 diabetes mellitus	6.04e-05	0.000402	CcSEcCtD
Indinavir—Somnolence—Metformin—type 2 diabetes mellitus	6.02e-05	0.000401	CcSEcCtD
Indinavir—Oedema—Losartan—type 2 diabetes mellitus	6.02e-05	0.0004	CcSEcCtD
Indinavir—Anaphylactic shock—Losartan—type 2 diabetes mellitus	6.02e-05	0.0004	CcSEcCtD
Indinavir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.01e-05	0.0004	CcSEcCtD
Indinavir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.97e-05	0.000397	CcSEcCtD
Indinavir—Dyspepsia—Metformin—type 2 diabetes mellitus	5.96e-05	0.000397	CcSEcCtD
Indinavir—CYP3A5—cortex of kidney—type 2 diabetes mellitus	5.94e-05	0.0221	CbGeAlD
Indinavir—Tremor—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000394	CcSEcCtD
Indinavir—Shock—Losartan—type 2 diabetes mellitus	5.92e-05	0.000394	CcSEcCtD
Indinavir—Urticaria—Valsartan—type 2 diabetes mellitus	5.91e-05	0.000393	CcSEcCtD
Indinavir—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.9e-05	0.000393	CcSEcCtD
Indinavir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.89e-05	0.000392	CcSEcCtD
Indinavir—Decreased appetite—Metformin—type 2 diabetes mellitus	5.89e-05	0.000392	CcSEcCtD
Indinavir—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.88e-05	0.000391	CcSEcCtD
Indinavir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.86e-05	0.00039	CcSEcCtD
Indinavir—Nausea—Bromocriptine—type 2 diabetes mellitus	5.86e-05	0.00039	CcSEcCtD
Indinavir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.85e-05	0.000389	CcSEcCtD
Indinavir—Fatigue—Metformin—type 2 diabetes mellitus	5.84e-05	0.000389	CcSEcCtD
Indinavir—Urticaria—Orlistat—type 2 diabetes mellitus	5.84e-05	0.000389	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000388	CcSEcCtD
Indinavir—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.82e-05	0.000387	CcSEcCtD
Indinavir—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.81e-05	0.000387	CcSEcCtD
Indinavir—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.81e-05	0.000387	CcSEcCtD
Indinavir—Asthenia—Gliclazide—type 2 diabetes mellitus	5.81e-05	0.000387	CcSEcCtD
Indinavir—Agitation—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000387	CcSEcCtD
Indinavir—Constipation—Metformin—type 2 diabetes mellitus	5.79e-05	0.000385	CcSEcCtD
Indinavir—Angioedema—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000384	CcSEcCtD
Indinavir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000382	CcSEcCtD
Indinavir—Anorexia—Losartan—type 2 diabetes mellitus	5.73e-05	0.000382	CcSEcCtD
Indinavir—Vomiting—Glyburide—type 2 diabetes mellitus	5.73e-05	0.000382	CcSEcCtD
Indinavir—Pruritus—Gliclazide—type 2 diabetes mellitus	5.73e-05	0.000381	CcSEcCtD
Indinavir—Malaise—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000379	CcSEcCtD
Indinavir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.000379	CcSEcCtD
Indinavir—ABCC2—liver—type 2 diabetes mellitus	5.7e-05	0.0212	CbGeAlD
Indinavir—Rash—Glyburide—type 2 diabetes mellitus	5.69e-05	0.000378	CcSEcCtD
Indinavir—Somnolence—Irbesartan—type 2 diabetes mellitus	5.68e-05	0.000378	CcSEcCtD
Indinavir—Dermatitis—Glyburide—type 2 diabetes mellitus	5.68e-05	0.000378	CcSEcCtD
Indinavir—Vertigo—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000378	CcSEcCtD
Indinavir—Syncope—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000377	CcSEcCtD
Indinavir—Headache—Glyburide—type 2 diabetes mellitus	5.65e-05	0.000376	CcSEcCtD
Indinavir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.63e-05	0.000374	CcSEcCtD
Indinavir—Palpitations—Ramipril—type 2 diabetes mellitus	5.59e-05	0.000372	CcSEcCtD
Indinavir—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.58e-05	0.000371	CcSEcCtD
Indinavir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.56e-05	0.00037	CcSEcCtD
Indinavir—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.56e-05	0.00037	CcSEcCtD
Indinavir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.54e-05	0.000369	CcSEcCtD
Indinavir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.54e-05	0.000369	CcSEcCtD
Indinavir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.000367	CcSEcCtD
Indinavir—Cough—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000367	CcSEcCtD
Indinavir—Fatigue—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000367	CcSEcCtD
Indinavir—CYP3A5—adipose tissue—type 2 diabetes mellitus	5.5e-05	0.0205	CbGeAlD
Indinavir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.48e-05	0.000365	CcSEcCtD
Indinavir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.48e-05	0.000365	CcSEcCtD
Indinavir—Pain—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000364	CcSEcCtD
Indinavir—Constipation—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000364	CcSEcCtD
Indinavir—Insomnia—Losartan—type 2 diabetes mellitus	5.44e-05	0.000362	CcSEcCtD
Indinavir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.42e-05	0.00036	CcSEcCtD
Indinavir—Paraesthesia—Losartan—type 2 diabetes mellitus	5.4e-05	0.000359	CcSEcCtD
Indinavir—Urticaria—Metformin—type 2 diabetes mellitus	5.38e-05	0.000358	CcSEcCtD
Indinavir—Arthralgia—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000358	CcSEcCtD
Indinavir—Myalgia—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000358	CcSEcCtD
Indinavir—Chest pain—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000358	CcSEcCtD
Indinavir—Dyspnoea—Losartan—type 2 diabetes mellitus	5.36e-05	0.000357	CcSEcCtD
Indinavir—Anxiety—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000357	CcSEcCtD
Indinavir—Nausea—Glyburide—type 2 diabetes mellitus	5.36e-05	0.000356	CcSEcCtD
Indinavir—Abdominal pain—Metformin—type 2 diabetes mellitus	5.36e-05	0.000356	CcSEcCtD
Indinavir—Dizziness—Gliclazide—type 2 diabetes mellitus	5.35e-05	0.000356	CcSEcCtD
Indinavir—Somnolence—Losartan—type 2 diabetes mellitus	5.35e-05	0.000356	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000356	CcSEcCtD
Indinavir—Asthenia—Valsartan—type 2 diabetes mellitus	5.34e-05	0.000355	CcSEcCtD
Indinavir—Discomfort—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000354	CcSEcCtD
Indinavir—Dyspepsia—Losartan—type 2 diabetes mellitus	5.3e-05	0.000352	CcSEcCtD
Indinavir—Asthenia—Orlistat—type 2 diabetes mellitus	5.27e-05	0.000351	CcSEcCtD
Indinavir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000351	CcSEcCtD
Indinavir—Pruritus—Valsartan—type 2 diabetes mellitus	5.26e-05	0.00035	CcSEcCtD
Indinavir—Dry mouth—Ramipril—type 2 diabetes mellitus	5.26e-05	0.00035	CcSEcCtD
Indinavir—Decreased appetite—Losartan—type 2 diabetes mellitus	5.23e-05	0.000348	CcSEcCtD
Indinavir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000348	CcSEcCtD
Indinavir—Pruritus—Orlistat—type 2 diabetes mellitus	5.2e-05	0.000346	CcSEcCtD
Indinavir—Fatigue—Losartan—type 2 diabetes mellitus	5.19e-05	0.000345	CcSEcCtD
Indinavir—Oedema—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000343	CcSEcCtD
Indinavir—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000343	CcSEcCtD
Indinavir—Vomiting—Gliclazide—type 2 diabetes mellitus	5.15e-05	0.000343	CcSEcCtD
Indinavir—Pain—Losartan—type 2 diabetes mellitus	5.14e-05	0.000342	CcSEcCtD
Indinavir—Constipation—Losartan—type 2 diabetes mellitus	5.14e-05	0.000342	CcSEcCtD
Indinavir—Rash—Gliclazide—type 2 diabetes mellitus	5.11e-05	0.00034	CcSEcCtD
Indinavir—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.1e-05	0.000339	CcSEcCtD
Indinavir—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.09e-05	0.000339	CcSEcCtD
Indinavir—Urticaria—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.000338	CcSEcCtD
Indinavir—Shock—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000338	CcSEcCtD
Indinavir—Headache—Gliclazide—type 2 diabetes mellitus	5.07e-05	0.000338	CcSEcCtD
Indinavir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000337	CcSEcCtD
Indinavir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.000336	CcSEcCtD
Indinavir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.000336	CcSEcCtD
Indinavir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000336	CcSEcCtD
Indinavir—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.03e-05	0.000335	CcSEcCtD
Indinavir—ABCC1—liver—type 2 diabetes mellitus	5.02e-05	0.0187	CbGeAlD
Indinavir—Skin disorder—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000333	CcSEcCtD
Indinavir—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000332	CcSEcCtD
Indinavir—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.96e-05	0.00033	CcSEcCtD
Indinavir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.92e-05	0.000327	CcSEcCtD
Indinavir—Dizziness—Valsartan—type 2 diabetes mellitus	4.92e-05	0.000327	CcSEcCtD
Indinavir—Anorexia—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000327	CcSEcCtD
Indinavir—CYP2C19—liver—type 2 diabetes mellitus	4.89e-05	0.0182	CbGeAlD
Indinavir—Dizziness—Orlistat—type 2 diabetes mellitus	4.86e-05	0.000323	CcSEcCtD
Indinavir—Asthenia—Metformin—type 2 diabetes mellitus	4.86e-05	0.000323	CcSEcCtD
Indinavir—Nausea—Gliclazide—type 2 diabetes mellitus	4.81e-05	0.00032	CcSEcCtD
Indinavir—Pruritus—Metformin—type 2 diabetes mellitus	4.79e-05	0.000319	CcSEcCtD
Indinavir—Urticaria—Losartan—type 2 diabetes mellitus	4.78e-05	0.000318	CcSEcCtD
Indinavir—Abdominal pain—Losartan—type 2 diabetes mellitus	4.76e-05	0.000316	CcSEcCtD
Indinavir—Body temperature increased—Losartan—type 2 diabetes mellitus	4.76e-05	0.000316	CcSEcCtD
Indinavir—Vomiting—Valsartan—type 2 diabetes mellitus	4.73e-05	0.000315	CcSEcCtD
Indinavir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.71e-05	0.000313	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000313	CcSEcCtD
Indinavir—Rash—Valsartan—type 2 diabetes mellitus	4.69e-05	0.000312	CcSEcCtD
Indinavir—Dermatitis—Valsartan—type 2 diabetes mellitus	4.69e-05	0.000312	CcSEcCtD
Indinavir—Vomiting—Orlistat—type 2 diabetes mellitus	4.67e-05	0.000311	CcSEcCtD
Indinavir—Insomnia—Ramipril—type 2 diabetes mellitus	4.67e-05	0.00031	CcSEcCtD
Indinavir—Headache—Valsartan—type 2 diabetes mellitus	4.66e-05	0.00031	CcSEcCtD
Indinavir—Diarrhoea—Metformin—type 2 diabetes mellitus	4.64e-05	0.000308	CcSEcCtD
Indinavir—Rash—Orlistat—type 2 diabetes mellitus	4.63e-05	0.000308	CcSEcCtD
Indinavir—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000308	CcSEcCtD
Indinavir—Dermatitis—Orlistat—type 2 diabetes mellitus	4.63e-05	0.000308	CcSEcCtD
Indinavir—Headache—Orlistat—type 2 diabetes mellitus	4.6e-05	0.000306	CcSEcCtD
Indinavir—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000306	CcSEcCtD
Indinavir—Asthenia—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000305	CcSEcCtD
Indinavir—Somnolence—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000305	CcSEcCtD
Indinavir—ABCB1—islet of Langerhans—type 2 diabetes mellitus	4.58e-05	0.0171	CbGeAlD
Indinavir—CYP3A4—kidney—type 2 diabetes mellitus	4.58e-05	0.0171	CbGeAlD
Indinavir—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.54e-05	0.000302	CcSEcCtD
Indinavir—Pruritus—Irbesartan—type 2 diabetes mellitus	4.52e-05	0.000301	CcSEcCtD
Indinavir—CYP2D6—kidney—type 2 diabetes mellitus	4.5e-05	0.0168	CbGeAlD
Indinavir—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.48e-05	0.000298	CcSEcCtD
Indinavir—Dizziness—Metformin—type 2 diabetes mellitus	4.48e-05	0.000298	CcSEcCtD
Indinavir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000296	CcSEcCtD
Indinavir—Fatigue—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000296	CcSEcCtD
Indinavir—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.43e-05	0.000295	CcSEcCtD
Indinavir—Nausea—Valsartan—type 2 diabetes mellitus	4.42e-05	0.000294	CcSEcCtD
Indinavir—Constipation—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000294	CcSEcCtD
Indinavir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000291	CcSEcCtD
Indinavir—Nausea—Orlistat—type 2 diabetes mellitus	4.37e-05	0.000291	CcSEcCtD
Indinavir—Asthenia—Losartan—type 2 diabetes mellitus	4.32e-05	0.000287	CcSEcCtD
Indinavir—Vomiting—Metformin—type 2 diabetes mellitus	4.31e-05	0.000287	CcSEcCtD
Indinavir—Rash—Metformin—type 2 diabetes mellitus	4.27e-05	0.000284	CcSEcCtD
Indinavir—Dermatitis—Metformin—type 2 diabetes mellitus	4.27e-05	0.000284	CcSEcCtD
Indinavir—Pruritus—Losartan—type 2 diabetes mellitus	4.26e-05	0.000283	CcSEcCtD
Indinavir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000283	CcSEcCtD
Indinavir—Headache—Metformin—type 2 diabetes mellitus	4.24e-05	0.000282	CcSEcCtD
Indinavir—Dizziness—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000281	CcSEcCtD
Indinavir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000281	CcSEcCtD
Indinavir—Diarrhoea—Losartan—type 2 diabetes mellitus	4.12e-05	0.000274	CcSEcCtD
Indinavir—Urticaria—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000273	CcSEcCtD
Indinavir—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000271	CcSEcCtD
Indinavir—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000271	CcSEcCtD
Indinavir—Vomiting—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.00027	CcSEcCtD
Indinavir—Rash—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.000268	CcSEcCtD
Indinavir—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.000268	CcSEcCtD
Indinavir—Nausea—Metformin—type 2 diabetes mellitus	4.02e-05	0.000268	CcSEcCtD
Indinavir—Headache—Irbesartan—type 2 diabetes mellitus	4e-05	0.000267	CcSEcCtD
Indinavir—Dizziness—Losartan—type 2 diabetes mellitus	3.98e-05	0.000265	CcSEcCtD
Indinavir—ABCB1—retina—type 2 diabetes mellitus	3.91e-05	0.0146	CbGeAlD
Indinavir—CYP3A5—liver—type 2 diabetes mellitus	3.86e-05	0.0144	CbGeAlD
Indinavir—Vomiting—Losartan—type 2 diabetes mellitus	3.83e-05	0.000255	CcSEcCtD
Indinavir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000253	CcSEcCtD
Indinavir—Nausea—Irbesartan—type 2 diabetes mellitus	3.8e-05	0.000253	CcSEcCtD
Indinavir—CYP2C9—liver—type 2 diabetes mellitus	3.79e-05	0.0141	CbGeAlD
Indinavir—Rash—Losartan—type 2 diabetes mellitus	3.79e-05	0.000252	CcSEcCtD
Indinavir—Dermatitis—Losartan—type 2 diabetes mellitus	3.79e-05	0.000252	CcSEcCtD
Indinavir—Headache—Losartan—type 2 diabetes mellitus	3.77e-05	0.000251	CcSEcCtD
Indinavir—Asthenia—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000246	CcSEcCtD
Indinavir—ABCB1—nephron tubule—type 2 diabetes mellitus	3.69e-05	0.0137	CbGeAlD
Indinavir—Pruritus—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000243	CcSEcCtD
Indinavir—Nausea—Losartan—type 2 diabetes mellitus	3.57e-05	0.000238	CcSEcCtD
Indinavir—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000235	CcSEcCtD
Indinavir—Dizziness—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000227	CcSEcCtD
Indinavir—ABCB1—cardiovascular system—type 2 diabetes mellitus	3.31e-05	0.0123	CbGeAlD
Indinavir—Vomiting—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000218	CcSEcCtD
Indinavir—Rash—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000216	CcSEcCtD
Indinavir—Dermatitis—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000216	CcSEcCtD
Indinavir—ABCB1—kidney—type 2 diabetes mellitus	3.24e-05	0.0121	CbGeAlD
Indinavir—Headache—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000215	CcSEcCtD
Indinavir—ABCB1—pancreas—type 2 diabetes mellitus	3.22e-05	0.012	CbGeAlD
Indinavir—ABCB1—cortex of kidney—type 2 diabetes mellitus	3.16e-05	0.0118	CbGeAlD
Indinavir—Nausea—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000204	CcSEcCtD
Indinavir—ABCB1—adipose tissue—type 2 diabetes mellitus	2.92e-05	0.0109	CbGeAlD
Indinavir—CYP3A4—liver—type 2 diabetes mellitus	2.89e-05	0.0108	CbGeAlD
Indinavir—CYP2D6—liver—type 2 diabetes mellitus	2.85e-05	0.0106	CbGeAlD
Indinavir—ABCB1—liver—type 2 diabetes mellitus	2.05e-05	0.00763	CbGeAlD
Indinavir—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	4.13e-06	7.32e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	4.11e-06	7.29e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.11e-06	7.28e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	4.1e-06	7.27e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	4.1e-06	7.26e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.1e-06	7.26e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	4.1e-06	7.26e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	4.05e-06	7.18e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.03e-06	7.14e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.02e-06	7.12e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.01e-06	7.11e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	3.98e-06	7.05e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	3.97e-06	7.03e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	3.97e-06	7.03e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	3.97e-06	7.03e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	3.96e-06	7.01e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.95e-06	7e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.95e-06	6.99e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.94e-06	6.97e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.94e-06	6.97e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.94e-06	6.97e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.9e-06	6.92e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.9e-06	6.92e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.9e-06	6.91e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	3.87e-06	6.86e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.86e-06	6.85e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.86e-06	6.84e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.85e-06	6.83e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.85e-06	6.81e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	3.84e-06	6.8e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.83e-06	6.78e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.81e-06	6.75e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.81e-06	6.75e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.81e-06	6.75e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	3.8e-06	6.73e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.79e-06	6.71e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.78e-06	6.7e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	3.78e-06	6.7e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.78e-06	6.7e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.78e-06	6.69e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.77e-06	6.68e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	3.76e-06	6.67e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	3.76e-06	6.66e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.75e-06	6.64e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.74e-06	6.63e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.74e-06	6.63e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	3.72e-06	6.59e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.72e-06	6.58e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	3.71e-06	6.57e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.65e-06	6.47e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.65e-06	6.47e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.64e-06	6.45e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.64e-06	6.45e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.64e-06	6.45e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.64e-06	6.45e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.63e-06	6.43e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	3.61e-06	6.4e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.6e-06	6.38e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.6e-06	6.37e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	3.6e-06	6.37e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.59e-06	6.36e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.59e-06	6.36e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	3.57e-06	6.33e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	3.56e-06	6.32e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.56e-06	6.31e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.56e-06	6.31e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	3.5e-06	6.21e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.5e-06	6.2e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.49e-06	6.19e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.47e-06	6.15e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	3.46e-06	6.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.45e-06	6.12e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	3.45e-06	6.11e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.44e-06	6.1e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.44e-06	6.1e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	3.42e-06	6.06e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.41e-06	6.05e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.41e-06	6.05e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	3.36e-06	5.95e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—SRC—type 2 diabetes mellitus	3.34e-06	5.92e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	3.3e-06	5.85e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	3.3e-06	5.85e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	3.29e-06	5.83e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.25e-06	5.76e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.25e-06	5.75e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.23e-06	5.72e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.23e-06	5.72e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.21e-06	5.69e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	3.21e-06	5.69e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.2e-06	5.66e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.18e-06	5.64e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.17e-06	5.61e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.15e-06	5.58e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.15e-06	5.58e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.15e-06	5.58e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.13e-06	5.55e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.09e-06	5.48e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.08e-06	5.45e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	3.07e-06	5.44e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.07e-06	5.44e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.03e-06	5.37e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.02e-06	5.35e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3e-06	5.32e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.99e-06	5.3e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	2.99e-06	5.29e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.97e-06	5.26e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.97e-06	5.26e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.97e-06	5.26e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.97e-06	5.26e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.95e-06	5.23e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.94e-06	5.21e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.94e-06	5.21e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.94e-06	5.2e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGFR—type 2 diabetes mellitus	2.93e-06	5.19e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.93e-06	5.19e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.92e-06	5.17e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.91e-06	5.16e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.91e-06	5.16e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.89e-06	5.13e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.89e-06	5.13e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.89e-06	5.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.89e-06	5.12e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.88e-06	5.1e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.88e-06	5.09e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.87e-06	5.08e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.87e-06	5.08e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.83e-06	5.01e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.82e-06	5.01e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.81e-06	4.98e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.81e-06	4.97e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.8e-06	4.97e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.8e-06	4.96e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.79e-06	4.95e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.79e-06	4.94e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.77e-06	4.91e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.76e-06	4.88e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.75e-06	4.88e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.73e-06	4.83e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.72e-06	4.83e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.72e-06	4.82e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.7e-06	4.79e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.69e-06	4.77e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.68e-06	4.74e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.64e-06	4.69e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.64e-06	4.69e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-06	4.67e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.62e-06	4.65e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.61e-06	4.63e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.6e-06	4.6e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.6e-06	4.6e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.6e-06	4.6e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.59e-06	4.6e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.58e-06	4.57e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.57e-06	4.55e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.55e-06	4.51e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.54e-06	4.51e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.53e-06	4.49e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.53e-06	4.49e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.53e-06	4.47e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.51e-06	4.45e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.51e-06	4.45e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.49e-06	4.42e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.47e-06	4.38e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.47e-06	4.38e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.46e-06	4.36e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.45e-06	4.35e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.43e-06	4.31e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.43e-06	4.31e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.41e-06	4.27e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.41e-06	4.27e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.4e-06	4.26e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-06	4.23e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.39e-06	4.23e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.39e-06	4.23e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.38e-06	4.21e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.37e-06	4.21e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.37e-06	4.19e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.35e-06	4.16e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.35e-06	4.16e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.31e-06	4.09e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.29e-06	4.06e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.27e-06	4.03e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.26e-06	4.01e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.25e-06	3.99e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—type 2 diabetes mellitus	2.25e-06	3.99e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.25e-06	3.99e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.25e-06	3.99e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.24e-06	3.98e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.24e-06	3.97e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.22e-06	3.93e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.18e-06	3.87e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.14e-06	3.8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.1e-06	3.73e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.09e-06	3.71e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—type 2 diabetes mellitus	2.08e-06	3.68e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.05e-06	3.64e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.97e-06	3.49e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.96e-06	3.46e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.94e-06	3.44e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.94e-06	3.44e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.93e-06	3.43e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.93e-06	3.42e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.93e-06	3.42e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.93e-06	3.42e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.92e-06	3.4e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.91e-06	3.38e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.88e-06	3.33e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.85e-06	3.28e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-06	3.27e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-06	3.27e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.8e-06	3.19e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.8e-06	3.19e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.8e-06	3.19e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.77e-06	3.14e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.77e-06	3.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.76e-06	3.12e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	1.74e-06	3.08e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.73e-06	3.06e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.72e-06	3.05e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-06	3.01e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-06	3.01e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.69e-06	2.99e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.68e-06	2.98e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.68e-06	2.98e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.68e-06	2.97e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.66e-06	2.94e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-06	2.93e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	2.92e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.59e-06	2.82e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.56e-06	2.76e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	2.75e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.54e-06	2.73e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.52e-06	2.69e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.51e-06	2.68e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.49e-06	2.63e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.48e-06	2.62e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.46e-06	2.59e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	1.41e-06	2.5e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.29e-06	2.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.26e-06	2.24e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.16e-06	2.05e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-06	1.97e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-06	1.97e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	1.94e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	1.8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.48e-07	1.5e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.27e-07	1.47e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.8e-07	1.38e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.73e-07	1.37e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.1e-07	9.03e-06	CbGpPWpGaD
